Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.

E A Elster; H Xu; D K Tadaki; S Montgomery; L C Burkly; J D Berning; R E Baumgartner; F Cruzata; R Marx; D M Harlan

doi:10.1097/00007890-200111150-00001

Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.

Identifier:nobleid.org/w1/20260515/AF22B6B2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF22B6B2.svg?ark=w1%2F20260515%2FAF22B6B2)](https://nobleid.org/work/w1/20260515/AF22B6B2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.

Identifier:nobleid.org/w1/20260515/AF22B6B2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF22B6B2.svg?ark=w1%2F20260515%2FAF22B6B2)](https://nobleid.org/work/w1/20260515/AF22B6B2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work